UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Breakthrough cytomegalovirus pneumonia in hematopoietic stem cell transplant recipient on letermovir prophylaxis

Bone marrow transplantation (Basingstoke), 2019-06, Vol.54 (6), p.911-912

2019

Volltextzugriff (PDF)

Therapy for relapsed acute lymphoblastic leukemia: Still a role for standard chemotherapy regimens?

Leukemia research, 2016-02, Vol.41, p.1-2

Seiter, Karen, MD

2016

Volltextzugriff (PDF)

High-Dose Vincristine Sulfate Liposome Injection for Advanced, Relapsed, and Refractory Adult Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia

Journal of clinical oncology, 2013-02, Vol.31 (6), p.676-683

2013

Volltextzugriff (PDF)

Clofarabine Plus Cytarabine Compared With Cytarabine Alone in Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia: Results From the CLASSIC I Trial

Journal of clinical oncology, 2012-07, Vol.30 (20), p.2492-2499

2012

Volltextzugriff (PDF)

Acute myeloid leukemia patients clinical response to idasanutlin (RG7388) is associated with pre-treatment MDM2 protein expression in leukemic blasts

Haematologica (Roma), 2016-05, Vol.101 (5), p.e185-e188

2016

Volltextzugriff (PDF)

Control of Plasma Uric Acid in Adults at Risk for Tumor Lysis Syndrome: Efficacy and Safety of Rasburicase Alone and Rasburicase Followed by Allopurinol Compared With Allopurinol Alone—Results of a Multicenter Phase III Study

Journal of clinical oncology, 2010-09, Vol.28 (27), p.4207-4213

2010

Volltextzugriff (PDF)

CLAG-Based Induction Therapy in Previously Untreated High Risk Acute Myeloid Leukemia Patients

Leukemia research, 2016-07, Vol.46, p.74-78

2016

Volltextzugriff (PDF)

Acute myeloid leukemia in a father and son with a germline mutation of ASXL1

Biomarker research, 2018-02, Vol.6 (1), p.7-3, Article 7

2018

Volltextzugriff (PDF)

Oral sapacitabine for the treatment of acute myeloid leukaemia in elderly patients: a randomised phase 2 study

The lancet oncology, 2012-11, Vol.13 (11), p.1096-1104

2012

Volltextzugriff (PDF)

Induction of ATM Activation, Histone H2AX Phosphorylation and Apoptosis by Etoposide: Relation to Cell Cycle Phase

Cell cycle (Georgetown, Tex.), 2007-02, Vol.6 (3), p.371-376

2007

Volltextzugriff (PDF)

Equity and Resource Allocation: The Case for Allogeneic Transplant in Emergency Medicaid Patients

Blood, 2023-11, Vol.142 (Supplement 1), p.7349-7349

2023

Volltextzugriff (PDF)

Management of Bone Marrow Transplants in Incarcerated Patients with Plasma Cell Dyscrasias: A Case Series

Blood, 2023-11, Vol.142 (Supplement 1), p.7350-7350

2023

Volltextzugriff (PDF)

Phase 1/1b Study of RG7388, a Potent MDM2 Antagonist, in Acute Myelogenous Leukemia (AML) Patients (Pts)

Blood, 2014-12, Vol.124 (21), p.116-116

2014

Volltextzugriff (PDF)

First Reported Case Series of Combined Treatment with CLAG and Venetoclax for Acute Myeloid Leukemia (AML)

Blood, 2022-11, Vol.140 (Supplement 1), p.11732-11733

2022

Volltextzugriff (PDF)

Patterns of Family History of Cancer in Adults with Hematologic Malignancies

Blood, 2021-11, Vol.138 (Supplement 1), p.4378-4378

2021

Volltextzugriff (PDF)

Toxicity of the topoisomerase II inhibitors

Expert opinion on drug safety, 2005-03, Vol.4 (2), p.219-234

Seiter, Karen

2005

Volltextzugriff (PDF)

Calr+ Myelofibrosis/BCR-ABL Chronic Myeloid Leukemia Overlap Syndrome Treated with Asciminib

Blood, 2023-11, Vol.142 (Supplement 1), p.6423-6423

2023

Volltextzugriff (PDF)

A Retrospective Pilot Study: Outcomes of R-Hypercvad in Aggressive Large B-Cell Lymphoma

Blood, 2022-11, Vol.140 (Supplement 1), p.12092-12093

2022

Volltextzugriff (PDF)

Management of mantle cell leukemia with cardiac involvement leading to cardiogenic shock

Frontiers of medicine, 2014-06, Vol.8 (2), p.254-258

2014

Volltextzugriff (PDF)

Myelodysplasia: New Approaches

Current treatment options in oncology, 2013-06, Vol.14 (2), p.156-169

Seiter, Karen

2013

Volltextzugriff (PDF)

DNA damage response as a biomarker in treatment of leukemias

Cell cycle (Georgetown, Tex.), 2009-06, Vol.8 (11), p.1720-1724

2009

Volltextzugriff (PDF)

t(8;14;18): a 3-way chromosome translocation in two patients with Burkitt's lymphoma/leukemia

Molecular cancer, 2007-06, Vol.6 (1), p.35-35

2007

Volltextzugriff (PDF)

CLAG-Based Chemotherapy in Previously Untreated AML Patients: 12 Year Follow-up

Blood, 2023-11, Vol.142 (Supplement 1), p.5913-5913

2023

Volltextzugriff (PDF)

Daratumumab for Refractory Autoimmune Leukopenia: A Case Report

Blood, 2023-11, Vol.142 (Supplement 1), p.5388-5388

2023

Volltextzugriff (PDF)

1 – 25 von 190

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(163)
Mit Volltextzugriff
(180)

Publikationsform

Sprache

Englisch
(190)

Erscheinungsjahr

n.n

Thema

Humans
(81)
Life Sciences & Biomedicine
(79)
Science & Technology
(79)
Oncology
(59)
Male
(51)
Female
(44)
Middle Aged
(44)
Hematology
(41)
Adult
(40)
Aged
(36)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(27)
Biological And Medical Sciences
(22)
Medical Sciences
(22)
Treatment Outcome
(20)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(17)
Leukemia, Myeloid, Acute - Drug Therapy
(17)
Chemotherapy
(16)
Aged, 80 And Over
(14)
Remission Induction
(13)
Pharmacology. Drug Treatments
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Breakthrough cytomegalovirus pneumonia in hematopoietic stem cell transplant recipient on letermovir prophylaxis

Therapy for relapsed acute lymphoblastic leukemia: Still a role for standard chemotherapy regimens?

High-Dose Vincristine Sulfate Liposome Injection for Advanced, Relapsed, and Refractory Adult Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia

Olutasidenib alone or with azacitidine in IDH1-mutated acute myeloid leukaemia and myelodysplastic syndrome: phase 1 results of a phase 1/2 trial

Clofarabine Plus Cytarabine Compared With Cytarabine Alone in Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia: Results From the CLASSIC I Trial

Acute myeloid leukemia patients clinical response to idasanutlin (RG7388) is associated with pre-treatment MDM2 protein expression in leukemic blasts

Control of Plasma Uric Acid in Adults at Risk for Tumor Lysis Syndrome: Efficacy and Safety of Rasburicase Alone and Rasburicase Followed by Allopurinol Compared With Allopurinol Alone—Results of a Multicenter Phase III Study

CLAG-Based Induction Therapy in Previously Untreated High Risk Acute Myeloid Leukemia Patients

Acute myeloid leukemia in a father and son with a germline mutation of ASXL1

Oral sapacitabine for the treatment of acute myeloid leukaemia in elderly patients: a randomised phase 2 study

Induction of ATM Activation, Histone H2AX Phosphorylation and Apoptosis by Etoposide: Relation to Cell Cycle Phase

Equity and Resource Allocation: The Case for Allogeneic Transplant in Emergency Medicaid Patients

Management of Bone Marrow Transplants in Incarcerated Patients with Plasma Cell Dyscrasias: A Case Series

Phase 1/1b Study of RG7388, a Potent MDM2 Antagonist, in Acute Myelogenous Leukemia (AML) Patients (Pts)

First Reported Case Series of Combined Treatment with CLAG and Venetoclax for Acute Myeloid Leukemia (AML)

Patterns of Family History of Cancer in Adults with Hematologic Malignancies

Toxicity of the topoisomerase II inhibitors

Calr+ Myelofibrosis/BCR-ABL Chronic Myeloid Leukemia Overlap Syndrome Treated with Asciminib

A Retrospective Pilot Study: Outcomes of R-Hypercvad in Aggressive Large B-Cell Lymphoma

Management of mantle cell leukemia with cardiac involvement leading to cardiogenic shock

Myelodysplasia: New Approaches

DNA damage response as a biomarker in treatment of leukemias

t(8;14;18): a 3-way chromosome translocation in two patients with Burkitt's lymphoma/leukemia

CLAG-Based Chemotherapy in Previously Untreated AML Patients: 12 Year Follow-up

Daratumumab for Refractory Autoimmune Leukopenia: A Case Report

Suchergebnisse filtern